Huge dividends from Denmark’s weight loss drug industry are result of high-tax and high-investment economy, says Nobel Prize winner Morten Meldal.

As results season winds down, Dan Jones and team discuss a property group’s results, alternative ways to find bargain stocks and Novo Nordisk vs Eli Lilly ...

Computational research in fruit flies revealed how spontaneously arising genes are tightly controlled, offering insights into ...

Eli Lilly is to raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170pc to be in line with other European markets, it has said, as the pharma industry responds ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...

Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven ...

The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

Three stocks that fall into that category today include Lululemon Athletica (NASDAQ: LULU), Novo Nordisk (NYSE: NVO), and ...